Summarize episode Ketamine: Benefits and Risks for Depression, PTSD & Neuroplasticity
Sources:
The episode examines ketamine’s potential mental-health benefits, how it may work, and its risks and delivery methods.
- Rapid relief and NMDA receptors: Ketamine can reduce depressive symptoms within minutes to hours, sometimes with relief lasting several days. It blocks NMDA receptors; through effects on inhibitory and excitatory neurons, it can promote BDNF-related neuroplasticity and changes in mood-related circuits.
- Potential uses: The episode discusses ketamine for treatment-resistant depression and suicidality, as well as bipolar depression, PTSD, OCD, anxiety, and some forms of substance addiction.
- Risks and dissociation: Ketamine can produce a dissociative, dreamlike state, and it has potential for abuse and dependence. Effects vary with dose and delivery; higher doses can cause anesthesia and may carry serious risks, so the episode emphasizes use in an appropriate clinical context.
- Administration methods: Clinical studies commonly use intravenous or intramuscular injections, while oral pills and sublingual forms are also used. Route affects how much active ketamine reaches the bloodstream; oral dosing delivers a smaller fraction, so routes differ in their effects and dosing considerations.
Answers are generated by AI and can contain mistakes.
Related questions

Take notes while listening to Huberman Lab

